Cargando…
Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma
Thin melanomas are tumors less than 1 mm thick according to Breslow classification. Their prognosis is in most cases excellent. However, a small subset of these tumors relapses. These clinical findings emphasize the need of novel prognostic biomarkers to identify this subset of tumors. Characterizat...
Autores principales: | Sabbatino, Francesco, Scognamiglio, Giosuè, Liguori, Luigi, Marra, Antonio, Anniciello, Anna Maria, Polcaro, Giovanna, Dal Col, Jessica, Caputo, Alessandro, Peluso, Anna Lucia, Botti, Gerardo, Zeppa, Pio, Ferrone, Soldano, Pepe, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550791/ https://www.ncbi.nlm.nih.gov/pubmed/33117345 http://dx.doi.org/10.3389/fimmu.2020.561390 |
Ejemplares similares
-
Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature
por: Sabbatino, Francesco, et al.
Publicado: (2018) -
Immune Checkpoint Inhibitors in Melanoma and HIV Infection
por: Marra, Antonio, et al.
Publicado: (2017) -
Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors
por: Liguori, Luigi, et al.
Publicado: (2022) -
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients
por: Sabbatino, Francesco, et al.
Publicado: (2020) -
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells
por: Botti, Gerardo, et al.
Publicado: (2017)